• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量热测试作为2型糖尿病和糖尿病前期患者糖尿病感觉运动性多发性神经病变的筛查及随访工具。

Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes.

作者信息

Huang Yu-Chuan, Chuang Yao-Chung, Chiu Wen-Chan, Huang Chih-Cheng, Cheng Ben-Chung, Kuo Chun-En Aurea, Lin Ting-Yin, Chiang Hui-Ching, Lai Yun-Ru

机构信息

Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Department of Neurology, Pao Chien Hospital, Pingtung, Taiwan.

出版信息

Front Neurosci. 2023 Mar 27;17:1115242. doi: 10.3389/fnins.2023.1115242. eCollection 2023.

DOI:10.3389/fnins.2023.1115242
PMID:37051142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10083326/
Abstract

INTRODUCTION

The diagnosis and assessment of neuropathy severity of diabetic sensorimotor polyneuropathy (DSPN) are mainly based on clinical neuropathy scores and electrophysiologic studies. This study aimed to determine whether quantitative thermal testing (QTT) can be used as a screening and follow-up tool for DSPN of prediabetes and type 2 diabetes at baseline and at 1-year follow-up.

METHODS

All patients were assessed using the Toronto Clinical Neuropathy Score (TCNS) and underwent electrophysiological testing, including a nerve conduction study (NCS) and QTT, at baseline and at a 1-year follow-up. The TCNS and the composite scores of nerve conduction were used to assess the severity of DSPN. The DSPN status at the 1-year follow-up was classified as remaining no DSPN, remaining DSPN, regression to no DSPN, or progression to DSPN.

RESULTS

Diabetic sensorimotor polyneuropathy was initially diagnosed in 89 patients with prediabetes and type 2 diabetes (22%). The regressed to no DSPN in 29 patients and progressed to DSPN in 20 patients at the 1-year follow-up. TCNS was significantly correlated with composite scores of nerve conduction, hand cold detection threshold (CDT), hand warm detection threshold (WDT), foot CDT, and foot WDT. Stepwise logistic regression demonstrated that the foot CDT ( < 0.0001) was independently associated with the presence of DSPN. The TCNS, composite scores of the nerve conduction, hand WDT, hand CDT, foot WDT, and foot CDT were all statistically significant among the four different DSPN status groups at two different time periods (baseline and the 1-year follow-up).

CONCLUSION

The foot CDT can be used as an initial screening tool for DSPN alternatively. The characteristics of nerve damage after 1 year of DSPN can be progressive or reversible, and the neurological functions of large and small fibers have a parallel trend, which can be objectively measured by NCS and QTT.

摘要

引言

糖尿病性感觉运动性多发性神经病变(DSPN)的诊断和神经病变严重程度评估主要基于临床神经病变评分和电生理研究。本研究旨在确定定量热测试(QTT)是否可作为糖尿病前期和2型糖尿病患者DSPN在基线和1年随访时的筛查及随访工具。

方法

所有患者均使用多伦多临床神经病变评分(TCNS)进行评估,并在基线和1年随访时接受电生理测试,包括神经传导研究(NCS)和QTT。TCNS和神经传导综合评分用于评估DSPN的严重程度。1年随访时的DSPN状态分为仍无DSPN、仍有DSPN、恢复至无DSPN或进展为DSPN。

结果

89例糖尿病前期和2型糖尿病患者(22%)最初被诊断为糖尿病性感觉运动性多发性神经病变。1年随访时,29例患者恢复至无DSPN,20例患者进展为DSPN。TCNS与神经传导综合评分、手部冷觉检测阈值(CDT)、手部温觉检测阈值(WDT)、足部CDT和足部WDT显著相关。逐步逻辑回归显示足部CDT(<0.0001)与DSPN的存在独立相关。在两个不同时间段(基线和1年随访)的四个不同DSPN状态组中,TCNS、神经传导综合评分、手部WDT、手部CDT、足部WDT和足部CDT均具有统计学意义。

结论

足部CDT可作为DSPN的替代初始筛查工具。DSPN 1年后神经损伤的特征可能是进行性的或可逆的,大小纤维的神经功能具有平行趋势,可通过NCS和QTT客观测量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee48/10083326/c51556fab46c/fnins-17-1115242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee48/10083326/e1464946a4fc/fnins-17-1115242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee48/10083326/c51556fab46c/fnins-17-1115242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee48/10083326/e1464946a4fc/fnins-17-1115242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee48/10083326/c51556fab46c/fnins-17-1115242-g002.jpg

相似文献

1
Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes.定量热测试作为2型糖尿病和糖尿病前期患者糖尿病感觉运动性多发性神经病变的筛查及随访工具。
Front Neurosci. 2023 Mar 27;17:1115242. doi: 10.3389/fnins.2023.1115242. eCollection 2023.
2
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.血清神经丝轻链:早期糖尿病感觉运动多发性神经病的新型生物标志物。
Diabetologia. 2023 Mar;66(3):579-589. doi: 10.1007/s00125-022-05846-8. Epub 2022 Dec 6.
3
Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes.基于纵向人工智能的深度学习模型,用于诊断和预测糖尿病和糖尿病前期多发性神经病的未来发生情况。
Neurophysiol Clin. 2024 Jul;54(4):102982. doi: 10.1016/j.neucli.2024.102982. Epub 2024 May 18.
4
Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.复合神经传导评分和体征用于诊断和躯体分期糖尿病多发性神经病:北美中东部种族队列研究。
Muscle Nerve. 2023 Jul;68(1):29-38. doi: 10.1002/mus.27793. Epub 2023 Mar 1.
5
Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.糖尿病远端对称性多发性神经病:2 型糖尿病患者的临床、实验室和电生理研究的相关性。
J Diabetes Res. 2020 Jul 3;2020:6356459. doi: 10.1155/2020/6356459. eCollection 2020.
6
Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.糖尿病早期神经纤维病变和功能障碍的 5 年进展和逆转。
Brain. 2021 Nov 29;144(10):3251-3263. doi: 10.1093/brain/awab330.
7
The Association between the Severity of Distal Sensorimotor Polyneuropathy and Increased Carotid Atherosclerosis in Individuals with Type 2 Diabetes.2型糖尿病患者远端感觉运动性多发性神经病严重程度与颈动脉粥样硬化增加之间的关联。
Diagnostics (Basel). 2024 Aug 31;14(17):1922. doi: 10.3390/diagnostics14171922.
8
Sensory Phenotypes Provide Insight Into the Natural Course of Diabetic Polyneuropathy.感觉表型为糖尿病多发性神经病的自然病程提供了深入了解。
Diabetes. 2024 Jan 1;73(1):135-146. doi: 10.2337/db23-0271.
9
Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study.患有糖尿病和糖尿病前期的老年患者常常没有意识到自己患有远端感觉运动多发性神经病:KORA F4 研究。
Diabetes Care. 2013 May;36(5):1141-6. doi: 10.2337/dc12-0744. Epub 2012 Dec 28.
10
Effectiveness of clinical alternatives to nerve conduction studies for screening for diabetic distal symmetrical polyneuropathy: A multi-center study.用于筛查糖尿病性远端对称性多发性神经病的神经传导研究临床替代方法的有效性:一项多中心研究。
Diabetes Res Clin Pract. 2016 May;115:150-6. doi: 10.1016/j.diabres.2016.01.002. Epub 2016 Jan 18.

引用本文的文献

1
An Overview on Diabetic Neuropathy.糖尿病神经病变概述
Curr Diabetes Rev. 2025;21(7):29-42. doi: 10.2174/0115733998295741240606104106.
2
Early detection of diabetic neuropathy based on health belief model: a scoping review.基于健康信念模型的糖尿病周围神经病变早期检测:系统评价。
Front Endocrinol (Lausanne). 2024 Apr 24;15:1369699. doi: 10.3389/fendo.2024.1369699. eCollection 2024.

本文引用的文献

1
Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.糖尿病早期神经纤维病变和功能障碍的 5 年进展和逆转。
Brain. 2021 Nov 29;144(10):3251-3263. doi: 10.1093/brain/awab330.
2
Small and large fiber sensory polyneuropathy in type 2 diabetes: Influence of diagnostic criteria on neuropathy subtypes.2 型糖尿病中小纤维感觉性多发性神经病:诊断标准对神经病变亚型的影响。
J Peripher Nerv Syst. 2021 Mar;26(1):55-65. doi: 10.1111/jns.12424. Epub 2020 Dec 13.
3
HbA1C Variability Is Strongly Associated with Development of Macroalbuminuria in Normal or Microalbuminuria in Patients with Type 2 Diabetes Mellitus: A Six-Year Follow-Up Study.
糖化血红蛋白变异性与 2 型糖尿病患者正常白蛋白尿或微量白蛋白尿进展到大白蛋白尿密切相关:一项为期六年的随访研究。
Biomed Res Int. 2020 Jan 25;2020:7462158. doi: 10.1155/2020/7462158. eCollection 2020.
4
Sural nerve sensory response in diabetic distal symmetrical polyneuropathy.糖尿病远端对称性多发性神经病中的腓肠神经感觉反应。
Muscle Nerve. 2020 Jan;61(1):88-94. doi: 10.1002/mus.26739. Epub 2019 Nov 1.
5
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7.遗传性转甲状腺素蛋白淀粉样变多发性神经病损伤测量指标的发展:从神经病变损害评分(NIS)到改良神经病变损害评分(mNIS)+7。
J Neurol Sci. 2019 Oct 15;405:116424. doi: 10.1016/j.jns.2019.116424. Epub 2019 Aug 8.
6
Diabetic neuropathy.糖尿病性神经病。
Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1.
7
HbA1C Variability Is Strongly Associated With the Severity of Peripheral Neuropathy in Patients With Type 2 Diabetes.糖化血红蛋白变异性与2型糖尿病患者周围神经病变的严重程度密切相关。
Front Neurosci. 2019 Feb 13;13:90. doi: 10.3389/fnins.2019.00090. eCollection 2019.
8
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.转甲状腺素蛋白家族性淀粉样多发性神经病(TTR-FAP):早期诊断的参数。
Brain Behav. 2017 Dec 19;8(1):e00889. doi: 10.1002/brb3.889. eCollection 2018 Jan.
9
Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy.APOLLO研究的试验设计与原理,这是一项针对遗传性转甲状腺素蛋白淀粉样变性多发性神经病患者的III期、安慰剂对照的帕替西兰研究。
BMC Neurol. 2017 Sep 11;17(1):181. doi: 10.1186/s12883-017-0948-5.
10
Assessing mNIS+7 and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.在一项家族性淀粉样多发性神经病试验中评估改良神经病变损害评分+7(mNIS+7)及国际神经科医生的专业水平。
Muscle Nerve. 2017 Nov;56(5):901-911. doi: 10.1002/mus.25563. Epub 2017 Apr 7.